For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Arm 1- Control | A group of hypertensive patients who receive usual care | None | None | 43 | 147 | 0 | 147 | View |
| Arm 2 - Nurse Behavioral Int | Nurse Behavioral intervention with Home BP Telemonitoring: Nurse-administered behavior intervention | None | None | 71 | 148 | 0 | 148 | View |
| Arm 3 - Nurse Med Managment Int | Nurse Medication Management with Home BP Telemonitoring: Nurse administer medication management according to hypertension decision support | None | None | 68 | 149 | 0 | 149 | View |
| Arm 4 - Combined Behavioral and Med Mgmt Int | Nurse Combined intervention with Home BP Telemonitoring: Combination of the nurse administered tailored behavioral \& medication management | None | None | 60 | 147 | 0 | 147 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Circulatory | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| w/recurrent nosebleed | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Cancer Tx | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Coronary | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Dermatologic | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Ear Pain | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | None | View |
| Endocrine | SYSTEMATIC_ASSESSMENT | Endocrine disorders | None | View |
| Eye | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Gastro-Intestinal | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| General - ER visits | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| General - Med-Refill | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| General - Med Side Effect | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Infections | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Injury | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Neurologic | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Optometry | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Orthopedic Issues | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Psychological | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Pulmonary | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Pulmonary-Death | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Renal | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Urology | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Vascular | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Coronary - Death | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Coronary Safety Protocol | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |